SUMMARY
INTRODUCTION
Frantz tumours or solid pseudopapillary tumours (SPTs) of the pancreas are rare. It is estimated that they correspond to 0.3% to 2.7% of all pancreatic tumors.
1, 2 Recently there has been an increase in its incidence, which may be related to the greater use of immunohistochemical methods. 3 There are several eponyms to denominate SPTs, such as: Hamoudi Tumor, Frantz Tumor and others. However, according to the World Health Organization (WHO) classification, the most appropriate nomenclature is solid pseudopapillary tumor of the pancreas. 
IMAGING IN MEDICINE
They are tumours of low malignant potential, which predominate in young women in the second to third decades of life.
5,6
Complete surgical resection is the curative treatment.
7, 8 SPTs are usually limited to the pancreas, allowing the resection of the entire lesion. Locoregional recurrence is estimated to occur in less than 10% to 15% of surgical resections.
9 Some factors are related to an increased risk of recurrence, such as lymphatic and vascular invasion, synchronic metastasis, and invasion of the tumor capsule. 10 In these cases, a more careful approach to long-term follow-up is needed.
7
In the imaging service of this oncology reference hospital, located in the city of São Paulo, we evidenced a case of recurrence of an SPT of the pancreas submitted to complete resection of the lesion with free margins. This is a case report obtained from imaging studies conducted in May 2015, before resection of the primary lesion, and in September 2017, after surgery, showing a new lesion.
Considering that SPT is a rare neoplasm, and that recurrence after free-margin resection is uncommon, we report this case with the purpose of reviewing the radiological findings of SPT in the literature, as well as knowing the incidence and risk factors of tumor recurrence.
CASE REPORT
GPSC, a 37-year-old Brazilian female was referred to the imaging department for pancreatic mass screening visualized in an imaging study from another hospital.
Initial nuclear magnetic resonance imaging (MRI) performed at the oncology centre in May 2015 included T1-weighted and T2-weighted images, intravenous paramagnetic contrast injection, fat saturation and diffusion sequences. It was characterized the increase of head/uncinate pancreas process at the expense of a mass, with a heterogeneous solid-cystic aspect, predominating hyposignal in T1, hypersignal in T2 and contrast enhanced, measuring 35 x 25 mm ( Figure 1 ). Such lesion had intimate contact with the proximal portion of the portal vein and spleno-mesenteric junction. No lymphadenopathy or dilatation of the intra-and extrahepatic bile ducts were observed. The remaining pancreatic parenchyma did not show significant changes.
Ultrasound-guided fine needle puncture (Paaf) was performed, which revealed findings compatible with SPT. The patient underwent complete resection of the lesion, with gastroduodenopancreatectomy and lymphadenectomy. Anatomopathological examination confirmed the presence of an SPT. Surgical margins and lymph nodes were free of neoplastic involvement. Immunohistochemical analysis was compatible with SPT.
After two years, another MRI study, performed with the same protocol as the previous examination, a solid, heterogeneous mass was identified with variable signal in T2, intermediate signal in T1, heterogeneous post-contrast enhancement, peripheral and with a tendency to homogenization in the late phases, located in the topography of the head/uncinate process of the pancreas, measuring 44 x 31 mm (Figure 2 ). This lesion showed proximity to the inferior vena cava and inferior mesenteric vein, but without signs of vascular invasion. The pancreatic duct had dimensions at the upper limit of normality. In view of the appearance of a new lesion after complete resection of the primary lesion, the possibility of tumor recurrence was considered, which was later confirmed by anatomopathological examination. SPTs have variable presentations on imaging tests. They are more common in the pancreatic tail and head.
5, 6 Generally, they are large, well-circumscribed, heterogeneous, solid-cystic masses at the expense of varying amounts of necrosis, haemorrhage, and cystic areas. 5 Calcifications may be present. 12 The solid component shows heterogeneous and progressive contrast enhancement. Dilatation of the biliary tract is rare
12
. MRI provides more information than computed tomography on the resectability and internal characteristics of the lesion, facilitating the identification of purely solid tumours and with smaller dimensions.
13
Complete surgical resection is the most efficient treatment, even in the presence of metastases or vascular invasion, and should be done for the primary lesion and for metastases if present. 7 Less than 10% to 15% of resections are estimated to evolve with recurrence. 9 In patients with signs of aggression, more careful follow-up is recommended, since recurrences may occur after five years of surgery. 7 In cases of relapse, surgical resection is also the most efficient treatment.
, 7
SPTs present a favourable prognosis, even when there are metastases, invasion or local recurrence.
7
In such cases, surgery is not a contraindication.
8
The case report refers to a patient with epidemiological and imaging characteristics compatible with SPT. An ultrasound-guided Paaf was used to distinguish neoplasm from other pancreatic tumours, allowing preoperative planning, since lesion resection is often curative. Despite this, the patient evolved with relapse after two years of surgery. SPT is a rare neoplasm with few cases of relapse after complete surgical resection. The importance of this case report lies in the correct diagnosis, since resection of the lesion is associated with long-term survival.
DISCUSSION
Most SPTs are benign. It is estimated that 10% to 15% are malignant. 11 Recurrence is related to signs of aggressive behaviour, characterized by: lymphatic and vascular invasion, synchronic metastasis and invasion of the tumor capsule.
10 Some studies suggest that tumours with a larger to 5 cm in diameter have greater malignant potential and risk of higher recurrence. 11 The high mitotic rate and nuclear atypia were also related to aggressive behavior
4
. Although these signs are related to the greater risk of relapse, their absence does not exclude the possibility that recurrence occurs in the long term. The most common sites of metastases are liver, portal vein, spleen, regional lymph nodes, omentum and peritoneum.
5,6
The diagnostic hypothesis is usually made through imaging tests, since the clinical status is nonspecific. Patients may be asymptomatic, report vague abdominal discomfort or symptoms related to the compression of adjacent structures by the tumor. 
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